In this review, we consolidate the available evidence derived from different SMA zebrafish models, including transient Smn knockdowns achieved via antisense morpholino oligonucleotide (MO) injections, transgenic lines, and pharmacological SMA models—schematized in Figure 1. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.